News

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016 [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous ...
Healio7h
Q&A: Allergic to the sun? Henry Lim, MD explains polymorphous light eruption
An extended day in the sun can be anything but relaxing for those who develop polymorphous light eruption, an uncomfortable, ...